Navigation Links
Haemacure financing receives shareholder consent - Series B Warrants are amended
Date:5/14/2008

May 29, 2008 and ending on June 12, 2008, Haemacure will issue to the holder, with each Haemacure common share purchased upon the exercise of Series B Warrants, one additional common share purchase warrant. Each additional warrant will entitle the holder to acquire one additional common share of Haemacure at a price of $0.25 until April 18, 2013.

If Series B Warrants are not exercised during the ten business-day period, the holder will not be entitled to receive the additional warrants upon the subsequent exercise of Series B Warrants. Holders of Series B Warrants who do not exercise them during the ten business-day period will retain the right to exercise the Series B Warrants in accordance with their original terms and conditions.

If all of the Series B Warrants are exercised during the ten business-day period, and all of the additional warrants are also exercised, Haemacure will issue a total of 62,500,000 common shares upon the exercise of the additional warrants, representing additional dilution of 38.2% when compared to the 163,800,917 common shares of Haemacure currently issued and outstanding.

The effective date of the amendment will be on the tenth business day after the issuance of this press release. The amendment to the terms and conditions of the Series B Warrants has been approved by the Toronto Stock Exchange, which required that the amendment be approved by Haemacure's shareholders, other than "insiders" of Haemacure who hold Series B Warrants. Haemacure relied on an exemption, set out in section 604(d) of the TSX Company Manual, from the requirement to call a shareholders' meeting to consider the amendment. Pursuant to the exemption, Haemacure provided written evidence to the TSX that holders of more than 50% of Haemacure's common shares (other than "insiders" of Haemacure who hold Series B Warrants) are familiar with the terms of the amendment and in favor of it. A total of nine "insiders" of Haemacure hold Series B Warrants. T
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
2. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
3. Haemacure Reports on its annual general and special meeting of shareholders
4. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
5. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
6. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
7. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
8. Haemacure Reports Third Quarter 2007 Results
9. InfoLogix Completes $25 Million Senior Debt Financing
10. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
11. Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... York, New York (PRWEB) July 11, 2014 ... http://www.transvaginalmeshlawsuithelp.com/ ) , filed against Johnson & Johnson’s ... courts, Bernstein Liebhard LLP notes that the Texas ... investigating the company’s marketing of surgical mesh products ... urinary incontinence. According to a report from kens5.com, ...
(Date:7/11/2014)... Butler Mobility has recently updated the paint color choices ... Previously the two standard colors were beige and brown. ... as standard colors at no additional charge! These colors ... enhance the beauty of the stairway. Homeowners will find ... individual décor. , The new selection of standard colors is: ...
(Date:7/11/2014)... News) -- Reducing the number of deer in an ... and other tick-borne infections among people, new research indicates. ... manipulated to reduce human interactions with deer, infected nymphal ... researchers wrote. White-tailed deer are the primary host ... people. The study included nearly all the permanent ...
(Date:7/11/2014)... (HealthDay News) -- People with the lowest incomes may have ... disease (PAD), a new study suggests. People with PAD ... limbs, most often the legs. The condition causes leg pain ... throughout the body. People with PAD have a higher risk ... nearly 6,800 people with PAD who took part in the ...
(Date:7/11/2014)... Dennis Thompson HealthDay Reporter ... Mississippi girl born with HIV who was thought to be ... new tests showing detectable levels of the AIDS-causing virus in ... girl, now nearly 4 years old, had remained virus-free even ... months old. Doctors had hoped her remission would open the ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2Health News:Poor More Prone to Leg Circulation Trouble 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3
... SAN FRANCISCO, Sept. 15 The Gladstone ... Quantitative Biomedical Research (QB3) at the University of California, ... (CDD) are pleased to announce the prestigious speakers and ... Drug Discovery - UCSF Community Meeting for Catalyzing Humanitarian ...
... (Sept. 15, 2009) A research project looking for ... of improving the bone health of cancer patients undergoing radiation ... microgravity environment of space causes bone loss in astronauts, but ... radiation on bones. Dr. Ted Bateman leads a project funded ...
... , , , ... the innovative healthcare company supporting the nation,s foremost cancer treatment and ... 2009 InformationWeek 500, an annual listing of the nation,s most innovative ... establishment of an enterprise-wide CRM platform. , , ...
... could improve long-term health, researchers say , TUESDAY, Sept. ... a greater risk of becoming obese in adulthood, new ... online Sept. 11 in the journal BMC Medicine ... Psychiatry Center at the Institute of Psychiatry at King,s ...
... , BURBANK, Calif., Sept. 15 ... Los Angeles and the Childrens Hospital Los Angeles Medical Group has ... treatment for a group that nationwide falls in a gap between ... The Adolescent & Young Adult Cancer Program ...
... Industries have ... million since ... and campaign ... and HMO political contributions and lobbying expenses found the industries spent $126,430,438 over the first half of 2009 and ...
Cached Medicine News:Health News:3rd Annual Collaborative Drug Discovery - UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 2Health News:3rd Annual Collaborative Drug Discovery - UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 3Health News:3rd Annual Collaborative Drug Discovery - UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 4Health News:Space-related radiation research could help reduce fractures in cancer survivors 2Health News:Space-related radiation research could help reduce fractures in cancer survivors 3Health News:US Oncology Named to InformationWeek 500 as Top User of Business Technology 2Health News:US Oncology Named to InformationWeek 500 as Top User of Business Technology 3Health News:US Oncology Named to InformationWeek 500 as Top User of Business Technology 4Health News:US Oncology Named to InformationWeek 500 as Top User of Business Technology 5Health News:US Oncology Named to InformationWeek 500 as Top User of Business Technology 6Health News:Anxious Kids at Risk for Obesity in Adulthood 2Health News:Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 2Health News:Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 3Health News:Insurance and HMO Industries Spend Nearly $700,000 Per Day to Kill Health Care Reform Measures 2
(Date:7/10/2014)... --  Ventana Medical Systems, Inc.  (Ventana), a member of ... an agreement with Merck KGaA, Darmstadt, Germany ... the United States and ... division on the development and commercialization of a companion ... diagnostic assays. In alignment with Merck KGaA,s strategic approach ...
(Date:7/10/2014)... July 10, 2014   LabStyle Innovations Corp ... today announced the appointment of Professor Richard ... its Board of Directors. Prof. Stone ... experience to LabStyle as an entrepreneur, venture capitalist ... corporate governance expert. He currently serves on the ...
(Date:7/10/2014)... BURLINGTON, Mass. , July 10, 2014 ... nephrologists report awareness of the U.S. Food and Drug ... Pharma,s new phosphate binder Velphoro, which was approved by ... hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis. ... TreatmentTrends: Nephrology (US) Q2 2014 ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: